Facebook
Linkedin
Tumblr
Twitter
Sign in
My Account
orders
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sign in / Join
Facebook
Linkedin
Tumblr
Twitter
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Market Exclusive
My Account
orders
Home
Tags
NYSE:AZN
Tag: NYSE:AZN
Analyst Upgrades – AstraZeneca (NYSE:AZN) Stock Gets Upgraded By Jefferies Group...
ME Staff
-
March 19, 2018
0
Analyst Activity – Leerink Swann Raises Its Price Target On AstraZeneca...
ME Staff
-
February 6, 2018
0
Analyst Activity – Sanford C. Bernstein Raises Its Price Target On...
ME Staff
-
February 5, 2018
0
AstraZeneca (NYSE:AZN) reported earnings of $1.30 per share beating Walls Streets...
ME Staff
-
February 2, 2018
0
AstraZeneca Just Scored Big On Late Stage COPD Data
-
January 29, 2018
0
Analyst Activity – BMO Capital Markets Reiterates Buy on AstraZeneca (NYSE:AZN)
ME Staff
-
January 26, 2018
0
Analyst Activity – Leerink Swann Reiterates Mkt Perform on AstraZeneca (NYSE:AZN)
ME Staff
-
January 18, 2018
0
AstraZeneca plc (ADR)(NYSE:AZN) Participates In ADC Therapeutics’ $200 Million Funding Round
-
October 24, 2017
0
FDA Accepts AstraZeneca plc (ADR)(NYSE:AZN) Imfinzi’s Supplemental Biologics License Application
Andy Parker
-
October 18, 2017
0
Analyst Activity – Cowen and Company Reiterates Hold on Astrazeneca PLC...
ME Staff
-
October 17, 2017
0
1
2
3
...
11
Page 2 of 11